Ornela Kutzke, MD
Plastic Surgery · Chevy Chase, MDNPI 1932597416
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,450 of the $5,364 with a category attached, or 64.3%. AbbVie accounts for 62.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $2,324 and has fallen 86.7% since, to $310 in 2025.
Across 30 payments — averaging $178.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lumenis BE Inc$2K
- Merz North America, Inc.$137
- Baxter Healthcare$66
- Acera Surgical, Inc.$31
- W. L. Gore & Associates, Inc.$28
- plus $33 from 2 others
What the payments were for
- Travel & lodging$1,91436%
- Food & beverage$3,45064%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $3,368 |
| Lumenis BE Inc | 1 | $1,700 |
| Merz North America, Inc. | 1 | $137 |
| Baxter Healthcare | 2 | $66 |
| Acera Surgical, Inc. | 1 | $31 |
| W. L. Gore & Associates, Inc. | 1 | $28 |
| Mentor Worldwide LLC | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$3,972
- REVOLVE$1,858
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$1,858
- M22$1,700
- STRATTICE$569
- ALLODERM$461
How this compares
$5,364 in reported general payments places this provider in the 70th percentile of 105 plastic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 21 | $1,094 |
| Gabapentin | 20 | $48 |
| Ondansetron Hcl | 14 | $24 |
| Oxycodone Hcl | 13 | $16 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Chevy Chase
- Samir RaoChevy Chase$26K
- Frank AlbinoChevy Chase$25K
- Navin SinghChevy Chase$16K
- James BrunoChevy Chase$5K
- Christopher BrownChevy Chase$4K
- Sheilah LynchChevy Chase$2K
- Wendell MilesChevy Chase$2K
- Chad GordonBaltimore$2.9M
- Larry LicksteinTowson$271K
- Sarah MessColumbia$178K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.